share_log

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga ·  Oct 14 08:08

Gainers

  • Tevogen Bio Holdings (NASDAQ:TVGN) shares rose 123.5% to $0.85 during Monday's pre-market session. The market value of their outstanding shares is at $144.7 million.
  • Inventiva (NASDAQ:IVA) shares increased by 67.19% to $3.16. The market value of their outstanding shares is at $165.4 million.
  • Longboard Pharmaceuticals (NASDAQ:LBPH) stock rose 51.28% to $58.85. The market value of their outstanding shares is at $2.2 billion.
  • Immuron (NASDAQ:IMRN) shares rose 18.18% to $2.6. The company's market cap stands at $14.8 million.
  • Jasper Therapeutics (NASDAQ:JSPR) stock increased by 15.05% to $17.27. The market value of their outstanding shares is at $260.8 million.
  • Rani Therapeutics Hldgs (NASDAQ:RANI) shares rose 13.86% to $2.3. The market value of their outstanding shares is at $67.3 million.

Losers

  • Molecular Templates (NASDAQ:MTEM) shares declined by 78.5% to $0.32 during Monday's pre-market session. The market value of their outstanding shares is at $2.0 million.
  • NewGenIvf Group (NASDAQ:NIVF) shares fell 16.77% to $0.82. The market value of their outstanding shares is at $8.2 million.
  • Dogwood Therapeutics (NASDAQ:DWTX) shares declined by 11.9% to $3.63. The company's market cap stands at $4.8 million.
  • HealthStream (NASDAQ:HSTM) shares declined by 8.87% to $26.0. The market value of their outstanding shares is at $790.6 million.
  • GRI Bio (NASDAQ:GRI) stock decreased by 7.74% to $0.37. The market value of their outstanding shares is at $1.0 million.
  • Virpax Pharmaceuticals (NASDAQ:VRPX) shares declined by 7.65% to $0.43. The market value of their outstanding shares is at $2.1 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment